May 13, 2024

Alarming Increase in New Cancer Cases

Alarming Increase in New Cancer Cases

By | May 15, 2024 

This year, for the first time ever, new cases of cancer in the U.S. are expected to surpass 2 million. The alarming increase follows a period of relative stability in new cancer cases prior to Covid. Experts disagree on the root cause. Some say it’s just a backlog after so many people put off screenings during the shutdowns.

But some researchers point to the mysterious spike protein in Covid and made in the vaccines. They say it’s causing “turbo cancers.” Dr. Nathan Goodyear is a medical doctor, an alternative treatment homeopath, and integrative oncologist. He became interested in specializing in cancer after he developed a tumor in his adrenal gland.

The following is a transcript of a report from “Full Measure with Sharyl Attkisson.” Watch the video by clicking the link at the end of the page.

Dr. Goodyear: Turbo Cancer describes what we see and what we’ve seen now for four years. And what we’re seeing with the pandemic is cancer changing. There was cancer pre-pandemic and there’s cancer post-pandemic. They are not the same thing.

Sharyl: Describe how they’re different.

Dr. Goodyear: You know, before the pandemic was predominantly one that we would say we were winning the war on. It’s predominantly one over the age of 50. What we are now seeing is a shifting geographics, younger and younger, more aggressive, and just weird things. I have seen many men, in fact in the last year, four men with breast cancer, many co-primaries, breast, pancreatic. These are rare, rare, rare things that you would see just a few instances in your clinical career. Other colleagues are seeing the same thing. And yet what we’re told is don’t believe your eyes and don’t believe your ears.

Sharyl: Can you describe a moment when you started to think post-Covid, or as it was underway, “There’s something different happening with the cancers here”?

Dr. Goodyear: I think the first thing I would say is when I saw a 28-year-old with stage four colorectal cancer early on in the pandemic. But when I saw a patient that was in remission that had done amazingly well, stage four breast cancer, huge mass, huge lymphedema on morphine, got completely off of it, negative PET CT scan, travels to Connecticut for Christmas, travels home, gets Covid, six weeks, cancer’s everywhere. And it doesn’t respond to nothing, doesn’t respond to anything. Those instances were a series of events, and that was the nail in the coffin that said, this is not the same thing.

Sharyl: Have you been able to identify what you think about Covid or the pandemic is causing what you’re calling turbo cancers?

Dr. Goodyear: Very clear in the literature. You take spike protein, whether injection or infection, doesn’t matter, it will bind in into a conglomerate with that lipopolysaccharide and accelerate inflammation by 50%. And inflammation is the chronic platform of chronic disease. And so that’ll accelerate cancer.

Sharyl: So aside from an awareness, because this is something people need to learn about and be aware of for anything to be done about it, what is it in terms of what you’re telling people ought to be done?

Dr. Goodyear: Get ahead of it. The power to heal and maximize your healing potential rests within us. I always tell all of our patients that we take better care of our cars than we do our own bodies. We also want to innovate in the arena of therapies that allow us to heal, not destroy. When you look at surgery, when you look at full dose chemo, both of those therapies have had advancements in medicine, there’s no doubt— I was a surgeon. But at the same time, both of those were born out of war. And with war, war destroys. War destroys the enemy, and war destroys everything around it. I think medicine needs a different approach. We need one that heals. Eliminate the tumor, but heal. So what we need to do is focus on therapies that heal.

Sharyl (on-camera): Dr. Goodyear is part of an effort now to test ivermectin in a study to find out whether it improves cancer survival.